{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T21:00:34Z","timestamp":1768078834423,"version":"3.49.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>In patients with diminished muscle mass, serum creatinine (SCr) levels may be misleadingly low, potentially leading to overestimations of kidney function and unexpectedly high blood levels of vancomycin. This study aimed to identify factors contributing to this discrepancy and develop a flowchart for stratifying the risk of excessive vancomycin exposure, measured as an upward deviation in the area under the concentration\u2013time curve (AUC) in patients with low SCr levels.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We analyzed data from patients who received vancomycin and had an SCr value &amp;lt;0.6\u00a0mg\/dL. The discrepancy between the AUC24\u201348\u00a0h initial dosing and AUC24\u201348\u00a0h TDM was calculated; a ratio (AUC24\u201348\u00a0h TDM\/AUC24\u201348\u00a0h initial dosing) higher than 1.2 defined an upward deviation in the AUC. A decision tree model was constructed using classification and regression tree algorithms.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among the 95 patients (median age [interquartile range], 69 [58, 80] years; 68% female), the upward AUC deviation was 40% (38\/95). Three factors (creatinine clearance: 115\u00a0ml\/min, age: 69 years, and blood urea nitrogen\/SCr: 17) were selected for the decision flowchart and included in four subgroups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>We developed a flowchart to identify patients with low SCr levels whose AUC at therapeutic drug monitoring deviated upward by &amp;gt;20% from the predicted AUC.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jpp\/rgaf038","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T07:29:04Z","timestamp":1748935744000},"page":"1255-1263","source":"Crossref","is-referenced-by-count":1,"title":["Risk stratification of AUC upward deviation in patients with low serum creatinine levels treated with vancomycin: a multicenter retrospective study"],"prefix":"10.1093","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2689-5338","authenticated-orcid":false,"given":"Tomoyuki","family":"Ishigo","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Sapporo Medical University Hospital , Sapporo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pharmacokinetics, School of Pharmacy, Kitasato University , Sagamihara ,","place":["Japan"]},{"name":"Department of Pharmacy, Kitasato University Hospital , Sagamihara ,","place":["Japan"]},{"name":"Department of Pharmacy, Showa Medical University Hospital , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Ibe","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Sapporo Medical University Hospital , Sapporo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Sapporo Medical University Hospital , Sapporo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahide","family":"Fukudo","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Sapporo Medical University Hospital , Sapporo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Kyorin University Hospital , Mitaka ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Kyorin University Hospital , Mitaka ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisato","family":"Fujihara","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmaceutics, School of Pharmacy, Showa Medical University , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiro","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Showa Medical University Fujigaoka Hospital , Yokohama ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiya","family":"Ebihara","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Tokyo Women\u2019s Medical University Hospital , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Maruyama","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Kochi Medical School Hospital , Kochi ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiro","family":"Hamada","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Tokyo Women\u2019s Medical University Hospital , Tokyo ,","place":["Japan"]},{"name":"Department of Pharmacy, Kochi Medical School Hospital , Kochi ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8637-1237","authenticated-orcid":false,"given":"Masaru","family":"Samura","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Yokohama General Hospital , Yokohama ,","place":["Japan"]},{"name":"Faculty of Pharmaceutical Sciences, Teikyo Heisei University , Tokyo ,","place":["Japan"]},{"name":"Division of Pharmacodynamics, Keio University Faculty of Pharmacy , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumio","family":"Nagumo","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Yokohama General Hospital , Yokohama ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Komatsu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Kitasato University Hospital , Sagamihara ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Tomizawa","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Kitasato University Hospital , Sagamihara ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akitoshi","family":"Takuma","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmaceutics, School of Pharmacy, Showa Medical University , Tokyo ,","place":["Japan"]},{"name":"Department of Pharmacy, Showa Medical University Northern Yokohama Hospital , Yokohama ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Chiba","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Tohoku Kosai Hospital , Sendai ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Nishi","sequence":"additional","affiliation":[{"name":"Center for Pharmacist Education, School of Pharmacy, Nihon University , Funabashi ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5934-0670","authenticated-orcid":false,"given":"Yuki","family":"Enoki","sequence":"additional","affiliation":[{"name":"Division of Pharmacodynamics, Keio University Faculty of Pharmacy , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3575-0448","authenticated-orcid":false,"given":"Kazuaki","family":"Taguchi","sequence":"additional","affiliation":[{"name":"Division of Pharmacodynamics, Keio University Faculty of Pharmacy , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5462-1684","authenticated-orcid":false,"given":"Kazuaki","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Division of Pharmacodynamics, Keio University Faculty of Pharmacy , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"key":"2025090400314456100_CIT0001","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1080\/14787210.2023.2275663","article-title":"Contemporary pharmacologic treatments of MRSA for hospitalized adults: rationale for vancomycin versus non-vancomycin therapies as first line agents","volume":"21","author":"Chang","year":"2023","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2025090400314456100_CIT0002","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3390\/pharmaceutics14030489","article-title":"Clinical practice guidelines for therapeutic drug monitoring of vancomycin in the framework of model-informed precision dosing: a consensus review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring","volume":"14","author":"Matsumoto","year":"2022","journal-title":"Pharmaceutics"},{"key":"2025090400314456100_CIT0003","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3390\/antibiotics11010096","article-title":"Validation of vancomycin area under the concentration\u2013time curve estimation by the Bayesian approach using one-point sample for predicting nephrotoxicity and clinical efficacy in patients with methicillin-resistant Staphylococcus aureus infections","volume":"11","author":"Ueda","year":"2022","journal-title":"Antibiotics"},{"key":"2025090400314456100_CIT0004","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12879-021-05858-6","article-title":"The monitoring of vancomycin: a systematic review and meta-analyses of area under the concentration-time curve-guided dosing and trough-guided dosing","volume":"21","author":"Tsutsuura","year":"2021","journal-title":"BMC Infect Dis"},{"key":"2025090400314456100_CIT0005","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2165\/00003088-198611040-00001","article-title":"Clinical pharmacokinetics of vancomycin","volume":"11","author":"Matzke","year":"1986","journal-title":"Clin Pharmacokinet"},{"key":"2025090400314456100_CIT0006","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1111\/ggi.13959","article-title":"Overestimation of glomerular filtration rate by creatinine-based equation in heart failure patients is predicted by a novel scoring system","volume":"20","author":"Ishigo","year":"2020","journal-title":"Geriatr Gerontol Int"},{"key":"2025090400314456100_CIT0007","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41581-018-0080-9","article-title":"Estimated GFR: time for a critical appraisal","volume":"15","author":"Porrini","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"2025090400314456100_CIT0008","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.jiac.2023.04.018","article-title":"Effect of renal clearance on vancomycin area under the concentration-time curve deviations in critically ill patients","volume":"29","author":"Ishigo","year":"2023","journal-title":"J Infect Chemother"},{"key":"2025090400314456100_CIT0009","doi-asserted-by":"publisher","first-page":"e0373923","DOI":"10.1128\/spectrum.03739-23","article-title":"Relationship between nephrotoxicity and area under the concentration-time curve of vancomycin in critically ill patients: a multicenter retrospective study","volume":"12","author":"Ishigo","year":"2024","journal-title":"Microbiol Spectr"},{"key":"2025090400314456100_CIT0010","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s11095-021-03030-y","article-title":"Performance of area under the concentration-time curve estimations of vancomycin with limited sampling by a newly developed web application","volume":"38","author":"Oda","year":"2021","journal-title":"Pharm Res"},{"key":"2025090400314456100_CIT0011","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"2025090400314456100_CIT0012","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1053\/j.ajkd.2012.07.007","article-title":"GFR estimation using standardized serum cystatin C in Japan","volume":"61","author":"Horio","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"2025090400314456100_CIT0013","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"2025090400314456100_CIT0014","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus definitions for sepsis and septic shock (sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"2025090400314456100_CIT0015","doi-asserted-by":"publisher","first-page":"c179","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"2025090400314456100_CIT0016","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1037\/pag0000046","article-title":"Using Classification and Regression Trees (CART) and random forests to analyze attrition: results from two simulations","volume":"30","author":"Hayes","year":"2015","journal-title":"Psychol Aging"},{"key":"2025090400314456100_CIT0017","doi-asserted-by":"publisher","first-page":"130","DOI":"10.11919\/j.issn.1002-0829.215044","article-title":"Decision tree methods: applications for classification and prediction","volume":"27","author":"Song","year":"2015","journal-title":"Shanghai Arch Psychiatry"},{"key":"2025090400314456100_CIT0018","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3390\/antibiotics9120920","article-title":"A risk prediction flowchart of vancomycin-induced acute kidney injury to use when starting vancomycin administration: a multicenter retrospective study","volume":"9","author":"Miyai","year":"2020","journal-title":"Antibiotics"},{"key":"2025090400314456100_CIT0019","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1097\/01.CCM.0000275267.64078.B0","article-title":"Assessing the calibration of mortality benchmarks in critical care: the Hosmer-Lemeshow test revisited","volume":"35","author":"Kramer","year":"2007","journal-title":"Crit Care Med"},{"key":"2025090400314456100_CIT0020","doi-asserted-by":"publisher","first-page":"9176","DOI":"10.5812\/ijcm.9176","article-title":"Survival prediction of patients with breast cancer: comparisons of decision tree and logistic regression analysis","volume":"11","author":"Momenyan","year":"2018","journal-title":"Int J Cancer Manag"},{"key":"2025090400314456100_CIT0021","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s10157-013-0811-y","article-title":"How to estimate kidney function in kidney transplant recipients with mild to moderate kidney impairment: comparison of estimated glomerular filtration (eGFR) values between creatinine-based GFR equations and cystatin C-based GFR equations for Japanese population","volume":"18","author":"Tsujita","year":"2014","journal-title":"Clin Exp Nephrol"},{"key":"2025090400314456100_CIT0022","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1080\/00365510902946992","article-title":"Different equations to combine creatinine and cystatin C to predict GFR. Arithmetic mean of existing equations performs as well as complex combinations","volume":"69","author":"Nyman","year":"2009","journal-title":"Scand J Clin Lab Invest"},{"key":"2025090400314456100_CIT0023","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1007\/s10157-024-02466-x","article-title":"Slope of the estimated glomerular filtration rate and its associated factors among individuals with chronic kidney disease in the general Japanese population","volume":"28","author":"Ito","year":"2024","journal-title":"Clin Exp Nephrol"},{"key":"2025090400314456100_CIT0024","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00540-018-2596-3","article-title":"Age-dependent error in creatinine clearance estimated by Cockcroft-Gault equation for the elderly patients in a Japanese hospital: a cross-sectional study","volume":"33","author":"Matsuo","year":"2019","journal-title":"J Anesth"},{"key":"2025090400314456100_CIT0025","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/s0272-6386(12)81022-5","article-title":"Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study","volume":"16","author":"Perrone","year":"1990","journal-title":"Am J Kidney Dis"},{"key":"2025090400314456100_CIT0026","first-page":"165","article-title":"Correlation between the creatinine clearance in the urine collected during 24 hours and 12 hours","volume":"32","author":"da Silva","year":"2010","journal-title":"J Bras Nefrol"},{"key":"2025090400314456100_CIT0027","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nrcardio.2017.51","article-title":"Muscle wasting and cachexia in heart failure: mechanisms and therapies","volume":"14","author":"von Haehling","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"2025090400314456100_CIT0028","doi-asserted-by":"publisher","first-page":"580","DOI":"10.23876\/j.krcp.21.214","article-title":"Serum cystatin C to creatinine ratio is associated with sarcopenia in non-dialysis-dependent chronic kidney disease","volume":"41","author":"An","year":"2022","journal-title":"Kidney Res Clin Pract"},{"key":"2025090400314456100_CIT0029","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1002\/jcsm.12977","article-title":"Serum creatinine and cystatin C-based diagnostic indices for sarcopenia in advanced non-small cell lung cancer","volume":"13","author":"Tang","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2025090400314456100_CIT0030","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.mehy.2011.06.044","article-title":"Reduced hydration status characterized by disproportionate elevation of blood urea nitrogen to serum creatinine among the patients with cerebral infarction","volume":"77","author":"Akimoto","year":"2011","journal-title":"Med Hypotheses"},{"key":"2025090400314456100_CIT0031","doi-asserted-by":"publisher","first-page":"182.e1","DOI":"10.1016\/j.amjmed.2009.05.031","article-title":"Vancomycin-associated nephrotoxicity: grave concern or death by character assassination","volume":"123","author":"Hazlewood","year":"2010","journal-title":"Am J Med"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/77\/9\/1255\/63500817\/rgaf038.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/77\/9\/1255\/63500817\/rgaf038.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T04:31:52Z","timestamp":1756960312000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/77\/9\/1255\/8163919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":31,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,6,16]]},"published-print":{"date-parts":[[2025,9,4]]}},"URL":"https:\/\/doi.org\/10.1093\/jpp\/rgaf038","relation":{},"ISSN":["0022-3573","2042-7158"],"issn-type":[{"value":"0022-3573","type":"print"},{"value":"2042-7158","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,6,16]]}}}